These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
3. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. Sirri E; Kieschke J; Vohmann C; Katalinic A; Nennecke A; Ressing M; Eberle A; Holleczek B; Jansen L; Brenner H; Int J Cancer; 2020 Sep; 147(6):1548-1558. PubMed ID: 32072636 [TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe. Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G; Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735 [TBL] [Abstract][Full Text] [Related]
5. Rare cancers of the head and neck area in Europe. Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L; Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735 [TBL] [Abstract][Full Text] [Related]
6. Rare cancers are not so rare: the rare cancer burden in Europe. Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R; Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323 [TBL] [Abstract][Full Text] [Related]
7. Carcinoma of endocrine organs: results of the RARECARE project. van der Zwan JM; Mallone S; van Dijk B; Bielska-Lasota M; Otter R; Foschi R; Baudin E; Links TP; Eur J Cancer; 2012 Sep; 48(13):1923-31. PubMed ID: 22361014 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of glial and non-glial brain tumours in Europe. Crocetti E; Trama A; Stiller C; Caldarella A; Soffietti R; Jaal J; Weber DC; Ricardi U; Slowinski J; Brandes A; Eur J Cancer; 2012 Jul; 48(10):1532-42. PubMed ID: 22227039 [TBL] [Abstract][Full Text] [Related]
9. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009. Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709 [TBL] [Abstract][Full Text] [Related]
10. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project. van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T; Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of rare cancers and inequalities in oncologic outcomes. Gatta G; Trama A; Capocaccia R; Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924 [TBL] [Abstract][Full Text] [Related]
12. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R; Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903 [TBL] [Abstract][Full Text] [Related]
13. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. Faivre J; Trama A; De Angelis R; Elferink M; Siesling S; Audisio R; Bosset JF; Cervantes A; Lepage C; Eur J Cancer; 2012 Jul; 48(10):1417-24. PubMed ID: 22169462 [TBL] [Abstract][Full Text] [Related]
14. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanaz E; Berrino F; Eur J Cancer; 2012 Jan; 48(2):159-69. PubMed ID: 22142457 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of malignant peritoneal mesothelioma: A population-based study. Salo SAS; Ilonen I; Laaksonen S; Myllärniemi M; Salo JA; Rantanen T Cancer Epidemiol; 2017 Dec; 51():81-86. PubMed ID: 29080447 [TBL] [Abstract][Full Text] [Related]
16. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009. Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956 [TBL] [Abstract][Full Text] [Related]
17. Estimates of cancer incidence and mortality in Europe in 1995. Bray F; Sankila R; Ferlay J; Parkin DM Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846 [TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
19. Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution. Orbach D; André N; Brecht IB; López Almaraz R; Ben-Ami T; Vermersch S; Carton M; Virgone C; Bisogno G; Schneider DT; Bajciova V; Reguerre Y; Galateau-Salle F; Stachowicz-Stencel T; Dvir R; Rees H; Bien E; Ferrari A; Ben Arush M Eur J Cancer; 2020 Nov; 140():63-70. PubMed ID: 33049597 [TBL] [Abstract][Full Text] [Related]
20. Malignant mesothelioma in Italy, 1997. Nesti M; Marinaccio A; Chellini E Am J Ind Med; 2004 Jan; 45(1):55-62. PubMed ID: 14691969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]